MiNK Therapeutics, Inc. Common Stock
INKT
INKT: MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses.
moreShow INKT Financials
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of INKT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by INKT's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on INKT's company Twitter account
WallStreetBets
Number of mentions of INKT in WallStreetBets Daily Discussion
INKT News
Recent insights relating to INKT
CNBC Recommendations
Recent picks made for INKT stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in INKT
Corporate Flights
Flights by private jets registered to INKT